Qualit-E-SpeakPharma-Insert
X

Find drug development pipeline and deal Updates information

A collaboration with SCORR Marketing

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type

            Companies

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): PeptiCRAd

            Therapeutic Area: Oncology

            Highest Development Status: Preclinical Product Type: Vaccine

            Partner/Sponsor/Collaborator: Finnish Funding Agency for Innovation

            Deal Size: $10.9 million Upfront Cash: $1.2 million

            Deal Type: Funding February 06, 2020

            Details:

            The funding will enable Valo Therapeutics to further validate their platform to develop antigen-coated oncolytic viruses as therapeutic vaccines.